Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Psychemedics Corporation - Common Stock (NQ: PMD )

2.670 UNCHANGED
Last Price Updated: 3:59 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Psychemedics Corporation - Common Stock

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Launches New Ketamine Hair Testing Service
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Reports First Quarter 2024 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Reports 2023 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
From Psychemedics Corporation
Via GlobeNewswire
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Psychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl. 
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
From Psychemedics Corporation
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.